Heart failure affects an estimated 64.3 million people worldwide
The company’s consolidated revenue from operations rose to Rs. 361.13 crore in Q2 FY26 and Rs. 707.67 crore for the first half
The Toumai platform, currently the only robotic system with US FDA Study Approval for telesurgery, enabled real-time surgical control with no compromise to patient safety
The company plans to use the newly secured funding to expand the indications of its Grabody platform into high-unmet-need areas
The initiative is focused on a problem that continues to plague cancer outcomes in India
The expansion includes a larger technical and service team and increased local procurement
The state-of-the-art facility is a 350-bedded, multi-specialty tertiary care hospital
The cobas Mass Spec solution Ionify reagent portfolio now covers therapeutic drug monitoring for immunosuppressants and antibiotics
The one-time CAR T cell infusion now becomes the first and only therapy of its kind cleared for this patient population
Subscribe To Our Newsletter & Stay Updated